These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 15857925

  • 21. Low hemoglobin, chronic kidney disease, and risk for coronary heart disease-related death: the Blue Mountains Eye Study.
    Leeder SR, Mitchell P, Liew G, Rochtchina E, Smith W, Wang JJ.
    J Am Soc Nephrol; 2006 Jan; 17(1):279-84. PubMed ID: 16319191
    [Abstract] [Full Text] [Related]

  • 22. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E, Cannella G.
    G Ital Nefrol; 2006 Jan; 23(6):560-8. PubMed ID: 17173262
    [Abstract] [Full Text] [Related]

  • 23. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.
    Hakeem A, Bhatti S, Dillie KS, Cook JR, Samad Z, Roth-Cline MD, Chang SM.
    Circulation; 2008 Dec 09; 118(24):2540-9. PubMed ID: 19047585
    [Abstract] [Full Text] [Related]

  • 24. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct 09; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 25. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.
    Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD.
    J Am Soc Nephrol; 2006 Oct 09; 17(10):2886-91. PubMed ID: 16928807
    [Abstract] [Full Text] [Related]

  • 26. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study.
    Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ.
    Am Heart J; 2006 Feb 09; 151(2):492-500. PubMed ID: 16442920
    [Abstract] [Full Text] [Related]

  • 27. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
    Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, Leip EP, O'donnell CJ, D'Agostino RB, Benjamin EJ.
    J Am Soc Nephrol; 2006 Feb 09; 17(2):521-7. PubMed ID: 16382018
    [Abstract] [Full Text] [Related]

  • 28. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
    Pasqualini L, Schillaci G, Pirro M, Vaudo G, Siepi D, Innocente S, Ciuffetti G, Mannarino E.
    J Intern Med; 2007 Dec 09; 262(6):668-77. PubMed ID: 17908164
    [Abstract] [Full Text] [Related]

  • 29. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Nephrol Dial Transplant; 2008 Dec 09; 23(12):3851-8. PubMed ID: 18641082
    [Abstract] [Full Text] [Related]

  • 30. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB.
    J Hum Hypertens; 2007 Aug 09; 21(8):625-32. PubMed ID: 17476291
    [Abstract] [Full Text] [Related]

  • 31. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
    McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, Parfrey P, Parving HH, Toto RM, Solomon SD, Pfeffer MA.
    Am Heart J; 2011 Oct 09; 162(4):748-755.e3. PubMed ID: 21982669
    [Abstract] [Full Text] [Related]

  • 32. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
    Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B.
    Am J Kidney Dis; 2008 Sep 09; 52(3):444-53. PubMed ID: 18468747
    [Abstract] [Full Text] [Related]

  • 33. Anemia and cardiovascular risk: the lesson of the CREATE Trial.
    Locatelli F, Del Vecchio L, Pozzoni P.
    J Am Soc Nephrol; 2006 Dec 09; 17(12 Suppl 3):S262-6. PubMed ID: 17130272
    [Abstract] [Full Text] [Related]

  • 34. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 35. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
    Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D.
    Adv Chronic Kidney Dis; 2007 Jan 15; 14(1):105-12. PubMed ID: 17200050
    [Abstract] [Full Text] [Related]

  • 36. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J, ERIC-HTA 2003 Study Investigators.
    J Hypertens; 2006 Apr 15; 24(4):663-9. PubMed ID: 16531794
    [Abstract] [Full Text] [Related]

  • 37. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A, Makusidi AM, Kolo PM.
    Ann Afr Med; 2012 Apr 15; 11(1):21-6. PubMed ID: 22199043
    [Abstract] [Full Text] [Related]

  • 38. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 15; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 39. Left ventricular hypertrophy and renal dysfunction during antihypertensive treatment adversely affect cardiovascular prognosis in hypertensive patients.
    Salvetti M, Muiesan ML, Paini A, Monteduro C, Agabiti-Rosei C, Aggiusti C, Bertacchini F, Stassaldi D, Castellano M, Agabiti-Rosei E.
    J Hypertens; 2012 Feb 15; 30(2):411-20. PubMed ID: 22179082
    [Abstract] [Full Text] [Related]

  • 40. Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study.
    Glynn LG, Reddan D, Newell J, Hinde J, Buckley B, Murphy AW.
    Nephrol Dial Transplant; 2007 Sep 15; 22(9):2586-94. PubMed ID: 17452408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.